Scientists discover a secret to regulating our body clock, offering new approach to end jet lag, sleep quality

Scientists from Duke-NUS Medical School and the University of California, Santa Cruz, have discovered the secret to regulating our internal clock. They identified that this regulator sits right at the tail end of Casein Kinase 1 delta (CK1δ), a protein which acts as a pace setter for our internal biological clock or the natural 24-hour cycles that control sleep-wake patterns and other daily functions, known as circadian rhythm.

Published in the journal PNAS, their findings could pave the way for new approaches to treating disorders related to our body clock.

CK1δ regulates circadian rhythms by tagging other proteins involved in our biological clock to fine-tune the timing of these rhythms. In addition to modifying other proteins, CK1δ itself can be tagged, thereby altering its own ability to regulate the proteins involved in running the body’s internal clock.

[…]

“Our findings pinpoint to three specific sites on CK1δ’s tail where phosphate groups can attach, and these sites are crucial for controlling the protein’s activity. When these spots get tagged with a phosphate group, CK1δ becomes less active, which means it doesn’t influence our circadian rhythms as effectively. Using high-resolution analysis, we were able to pinpoint the exact sites involved — and that’s really exciting.”

[…]

We found that the δ1 tail interacts more extensively with the main part of the protein, leading to greater self-inhibition compared to δ2. This means that δ1 is more tightly regulated by its tail than δ2. When these sites are mutated or removed, δ1 becomes more active, which leads to changes in circadian rhythms. In contrast, δ2 does not have the same regulatory effect from its tail region.”

This discovery highlights how a small part of CK1δ can greatly influence its overall activity. This self-regulation is vital for keeping CK1δ activity balanced, which, in turn, helps regulate our circadian rhythms.

The study also addressed the wider implications of these findings. CK1δ plays a role in several important processes beyond circadian rhythms, including cell division, cancer development, and certain neurodegenerative diseases. By better understanding how CK1δ’s activity is regulated, scientists could open new avenues for treating not just circadian rhythm disorders but also a range of conditions.

[…]

“Regulating our internal clock goes beyond curing jet lag — it’s about improving sleep-quality, metabolism and overall health. This important discovery could potentially open new doors for treatments that could transform how we manage these essential aspects of our daily lives.”

The researchers plan to further investigate how real-world factors, such as diet and environmental changes, affect the tagging sites on CK1δ.

[…]

Story Source:

Materials provided by Duke-NUS Medical School. Note: Content may be edited for style and length.


Journal Reference:

  1. Rachel L. Harold, Nikhil K. Tulsian, Rajesh Narasimamurthy, Noelle Yaitanes, Maria G. Ayala Hernandez, Hsiau-Wei Lee, Priya Crosby, Sarvind M. Tripathi, David M. Virshup, Carrie L. Partch. Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein kinase 1. Proceedings of the National Academy of Sciences, 2024; 121 (41) DOI: 10.1073/pnas.2415567121

Source: Scientists discover a secret to regulating our body clock, offering new approach to end jet lag | ScienceDaily

Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine over hiking unique life saving drug price from $13.50 to $750 a pill

Martin Shkreli has been fighting a $64.6 million fine he acquired in 2022 for blocking affordable alternatives to Daraprim, a lifesaving antiparasitic drug. Shockingly, it turns out nobody on the Supreme Court cares to hear about it.

No justices dissented on Monday when the court said it declined to hear an appeal by representatives of the former pharmaceutical executive. In a last-ditch effort, Shkreli’s lawyers asked the Supreme Court to resolve conflicting rulings after the 2nd U.S. Circuit Court of Appeals upheld the $64.6 million order and a lifetime ban to block Shkreli from working in the drug business. Only, the conflicting rulings didn’t even exist, New York Attorney General Letitia James argued in an August brief. The Supreme Court had nothing to add when it snubbed Shkreli.

The so-called “pharma bro” rose to infamy as the chief of Turing Pharmaceuticals — later called Vyera. In 2015, the startup bought exclusive rights to Daraprim and jacked up its price from $13.50 to $750 a pill. At the time, there were no generic alternatives to the toxoplasmosis medication, which is used to treat a rare condition that affects pregnant people, babies, and people with HIV and cancer.

Shkreli, also temporarily the owner of a secret Wu-Tang Clan album, was convicted of securities fraud and sentenced to seven years in prison in a 2017 case unrelated to Daraprim. In a comment to Gizmodo at the time, Shkreli said he planned to “make paper from inside” while serving time. Two years later, the former executive reportedly faced solitary confinement for trying to run a company with a contraband phone.

Shkreli got out of prison in 2022 and promptly announced a Web3-based drug discovery venture called Druglike. His other recent projects include launching a medical chatbot called Dr. Gupta and taking credit for a cryptocurrency named after former President Donald Trump.

Turing filed for bankruptcy and moved to sell the rights to Daraprim in 2023.

Source: Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine

Epic judge orders Google to let rivals set up app stores

A US court has ordered Google to refrain from a wide variety of business practices the web giant uses to bolster its Play Store, as a consequence of its December 2023 antitrust defeat against Epic Games.

In that case, Epic argued that Google’s Play Store rules and contractual agreements with developers and partners violated the federal Sherman Act and California’s Unfair Competition Law (UCL). And the jury agreed.

On Monday, US District Court judge James Donato issued a permanent injunction [PDF] that forbids Google from eight behaviors deemed unlawful as a result of the case.

“The jury found that Google’s conduct violated the antitrust laws and substantially harmed competition in the relevant markets, and directly injured Epic,” judge Donato wrote, explaining the injunction. “The jury rejected Google’s proffered procompetitive justifications for its conduct. Consequently, the Court concludes that Epic has prevailed on the UCL claim against Google under the unlawful and unfair prongs.”

Noting that Google had “fired a blunderbuss of comments and complaints that are underdeveloped and consequently unhelpful in deciding the issues,” judge Donato put an end to the extensive input afforded to both sides about the specifics of the injunction that follows from the verdict.

Google, in a blog post, unsurprisingly disagreed – it is appealing the verdict and will ask the courts to pause the injunction until its appeal is heard.

“These Epic-requested changes stem from a decision that is completely contrary to another court’s rejection of similar claims Epic made against Apple – even though, unlike iOS, Android is an open platform that has always allowed for choice and flexibility like multiple app stores and sideloading,” wrote Lee-Anne Mulholland, VP of regulatory affairs at Google.

Mulholland argues that the court-ordered changes would hinder Google’s – and the wider Android ecosystem’s – ability to compete with Apple’s ecosystem.

The injunction is set to take effect starting November 1, 2024, only in the US, for a period of three years. During this time:

  • Google may not share revenue generated by the Google Play Store with any person or entity that distributes Android apps, or has stated that it will launch or is considering launching an Android app distribution platform or store.
  • Google may not condition a payment, revenue share, or access to any Google product or service …
    • on an agreement by an app developer to launch an app first or exclusively in the Google Play Store;
    • on an agreement by an app developer not to launch on a third-party Android app distribution platform or store a version of an app that includes features not available in, or is otherwise different from, the version of the app offered on the Google Play Store;
    • on an agreement with an original equipment manufacturer (OEM) or carrier …
      • to preinstall the Google Play Store on any specific location on an Android device;
      • not to preinstall an Android app distribution platform or store other than the Google Play Store.
  • Google may not …
    • require the use of Google Play Billing in apps distributed on the Google Play Store, or prohibit the use of in-app payment methods other than Google Play Billing;
    • prohibit a developer from communicating with users about the availability of a payment method other than Google Play Billing;
    • require a developer to set a price based on whether Google Play Billing is used;
    • prohibit a developer from …
      • communicating with users about the availability or pricing of an app outside the Google Play Store;
      • providing a link to download the app outside the Google Play Store.
  • Google will permit third-party Android app stores to access the Google Play Store’s catalog of apps so that they may offer the Play Store apps to users. [Along with other distribution fairness requirements, Google has eight-months to implement this, at which point the three-year clock will begin for this provision.]
  • Google may not prohibit the distribution of third-party Android app distribution platforms or stores through the Google Play Store.

The injunction also gives Epic and Google a 30-day deadline to form a three-person Technical Committee, comprising one representative from each party and a mutually agreed upon third member, to resolve disputes over the implementation of the injunction’s provisions.

Epic Games did not immediately respond to a request for comment. ®

Source: Epic judge orders Google to let rivals set up app stores • The Register